APO RESEARCH · REPORT
Atropine
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system. Atropine occurs naturally in a number of plants of the nightshade family including deadly nightshade, Jimson weed, and mandrake. It was first isolated in 1833. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive.
Product & engineering
Understand the product.
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system. Atropine occurs naturally in a number of plants of the nightshade family including deadly nightshade, Jimson weed, and mandrake. It was first isolated in 1833. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive.
Selected research
Industry Research
Atropine Industry Research Report 2026
Market perspective
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system. Atropine occurs naturally in a number of plants of the nightshade family including deadly nightshade, Jimson weed, and mandrake. It was first isolated in 1833. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive.
Global Atropine key players include C²PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, CR Double-Crane, Katsura Chemical, etc. Global top five manufacturers hold a share about 35%. China, Europe and North America is the largest market, each with a share about 25%, followed by Japan, with a share about 15 percent. In terms of product, Injection is the largest segment, with a share about 80%. And in terms of application, the largest application is Gastrointestinal, followed by Ophthalmology, etc.
Report Scope
Read the full market overview
This report quantifies the global Atropine market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Atropine Market by Company
C²PHARMA
RESONANCE LABORATORIES
ROLABO OUTSOURCING
Minsheng
CR Double-Crane
HENAN PURUI
Albany Molecular Research
Alchem International
SAURAV CHEMICALS
Katsura Chemical
Hangzhou Vega
Wuhan senwayer century
Atropine Segment by Type
Injection
Drop
Gel
Atropine Segment by Application
Gastrointestinal
Ophthalmology
Other
Atropine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atropine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Atropine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atropine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Atropine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Atropine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Atropine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Drop
- Gel
Applications
- Gastrointestinal
- Ophthalmology
- Other
Companies covered
- C²PHARMA
- RESONANCE LABORATORIES
- ROLABO OUTSOURCING
- Minsheng
- CR Double-Crane
- HENAN PURUI
- Albany Molecular Research
- Alchem International
- SAURAV CHEMICALS
- Katsura Chemical
- Hangzhou Vega
- Wuhan senwayer century
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Atropine Market Size (2021-2032)
- 2.2.2 Global Atropine Sales (2021-2032)
- 2.2.3 Global Atropine Market Average Price (2021-2032)
- 2.3 Atropine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injection
- 2.3.3 Drop
- 2.3.4 Gel
- 2.4 Atropine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Gastrointestinal
- 2.4.3 Ophthalmology
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Atropine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Atropine Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Atropine Revenue of Manufacturers (2021-2026)
- 3.4 Global Atropine Average Price by Manufacturers (2021-2026)
- 3.5 Global Atropine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Atropine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Atropine, Product Type & Application
- 3.8 Global Manufacturers of Atropine, Established Date
- 3.9 Global Atropine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 C²PHARMA
- 4.1.1 C²PHARMA Company Information
- 4.1.2 C²PHARMA Business Overview
- 4.1.3 C²PHARMA Atropine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 C²PHARMA Atropine Product Portfolio
- 4.1.5 C²PHARMA Recent Developments
- 4.2 RESONANCE LABORATORIES
- 4.2.1 RESONANCE LABORATORIES Company Information
- 4.2.2 RESONANCE LABORATORIES Business Overview
- 4.2.3 RESONANCE LABORATORIES Atropine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 RESONANCE LABORATORIES Atropine Product Portfolio
- 4.2.5 RESONANCE LABORATORIES Recent Developments
- 4.3 ROLABO OUTSOURCING
- 4.3.1 ROLABO OUTSOURCING Company Information
- 4.3.2 ROLABO OUTSOURCING Business Overview
- 4.3.3 ROLABO OUTSOURCING Atropine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 ROLABO OUTSOURCING Atropine Product Portfolio
- 4.3.5 ROLABO OUTSOURCING Recent Developments
- 4.4 Minsheng
- 4.4.1 Minsheng Company Information
- 4.4.2 Minsheng Business Overview
- 4.4.3 Minsheng Atropine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Minsheng Atropine Product Portfolio
- 4.4.5 Minsheng Recent Developments
- 4.5 CR Double-Crane
- 4.5.1 CR Double-Crane Company Information
- 4.5.2 CR Double-Crane Business Overview
- 4.5.3 CR Double-Crane Atropine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 CR Double-Crane Atropine Product Portfolio
- 4.5.5 CR Double-Crane Recent Developments
- 4.6 HENAN PURUI
- 4.6.1 HENAN PURUI Company Information
- 4.6.2 HENAN PURUI Business Overview
- 4.6.3 HENAN PURUI Atropine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 HENAN PURUI Atropine Product Portfolio
- 4.6.5 HENAN PURUI Recent Developments
- 4.7 Albany Molecular Research
- 4.7.1 Albany Molecular Research Company Information
- 4.7.2 Albany Molecular Research Business Overview
- 4.7.3 Albany Molecular Research Atropine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Albany Molecular Research Atropine Product Portfolio
- 4.7.5 Albany Molecular Research Recent Developments
- 4.8 Alchem International
- 4.8.1 Alchem International Company Information
- 4.8.2 Alchem International Business Overview
- 4.8.3 Alchem International Atropine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Alchem International Atropine Product Portfolio
- 4.8.5 Alchem International Recent Developments
- 4.9 SAURAV CHEMICALS
- 4.9.1 SAURAV CHEMICALS Company Information
- 4.9.2 SAURAV CHEMICALS Business Overview
- 4.9.3 SAURAV CHEMICALS Atropine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 SAURAV CHEMICALS Atropine Product Portfolio
- 4.9.5 SAURAV CHEMICALS Recent Developments
- 4.10 Katsura Chemical
- 4.10.1 Katsura Chemical Company Information
- 4.10.2 Katsura Chemical Business Overview
- 4.10.3 Katsura Chemical Atropine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Katsura Chemical Atropine Product Portfolio
- 4.10.5 Katsura Chemical Recent Developments
- 4.11 Hangzhou Vega
- 4.11.1 Hangzhou Vega Company Information
- 4.11.2 Hangzhou Vega Business Overview
- 4.11.3 Hangzhou Vega Atropine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Hangzhou Vega Atropine Product Portfolio
- 4.11.5 Hangzhou Vega Recent Developments
- 4.12 Wuhan senwayer century
- 4.12.1 Wuhan senwayer century Company Information
- 4.12.2 Wuhan senwayer century Business Overview
- 4.12.3 Wuhan senwayer century Atropine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Wuhan senwayer century Atropine Product Portfolio
- 4.12.5 Wuhan senwayer century Recent Developments
5 Global Atropine Market Scenario by Region
- 5.1 Global Atropine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Atropine Sales by Region: 2021-2032
- 5.2.1 Global Atropine Sales by Region: 2021-2026
- 5.2.2 Global Atropine Sales by Region: 2027-2032
- 5.3 Global Atropine Revenue by Region: 2021-2032
- 5.3.1 Global Atropine Revenue by Region: 2021-2026
- 5.3.2 Global Atropine Revenue by Region: 2027-2032
- 5.4 North America Atropine Market Facts & Figures by Country
- 5.4.1 North America Atropine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Atropine Sales by Country (2021-2032)
- 5.4.3 North America Atropine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Atropine Market Facts & Figures by Country
- 5.5.1 Europe Atropine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Atropine Sales by Country (2021-2032)
- 5.5.3 Europe Atropine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Atropine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Atropine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Atropine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Atropine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Atropine Market Facts & Figures by Country
- 5.7.1 South America Atropine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Atropine Sales by Country (2021-2032)
- 5.7.3 South America Atropine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Atropine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Atropine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Atropine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Atropine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Atropine Sales by Type (2021-2032)
- 6.1.1 Global Atropine Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Atropine Sales Market Share by Type (2021-2032)
- 6.2 Global Atropine Revenue by Type (2021-2032)
- 6.2.1 Global Atropine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Atropine Revenue Market Share by Type (2021-2032)
- 6.3 Global Atropine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Atropine Sales by Application (2021-2032)
- 7.1.1 Global Atropine Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Atropine Sales Market Share by Application (2021-2032)
- 7.2 Global Atropine Revenue by Application (2021-2032)
- 7.2.1 Global Atropine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Atropine Revenue Market Share by Application (2021-2032)
- 7.3 Global Atropine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Atropine Value Chain Analysis
- 8.1.1 Atropine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Atropine Production Mode & Process
- 8.2 Atropine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Atropine Distributors
- 8.2.3 Atropine Customers
9 Global Atropine Analyzing Market Dynamics
- 9.1 Atropine Industry Trends
- 9.2 Atropine Industry Drivers
- 9.3 Atropine Industry Opportunities and Challenges
- 9.4 Atropine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst